Literature DB >> 22377579

Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases.

Mark S LeDoux1, Jianfeng Xiao, Monika Rudzińska, Robert W Bastian, Zbigniew K Wszolek, Jay A Van Gerpen, Andreas Puschmann, Dragana Momčilović, Satya R Vemula, Yu Zhao.   

Abstract

An extensive variety of THAP1 sequence variants have been associated with focal, segmental and generalized dystonia with age of onset ranging from 3 to over 60 years. In previous work, we screened 1114 subjects with mainly adult-onset primary dystonia (Neurology 2010; 74:229-238) and identified 6 missense mutations in THAP1. For this report, we screened 750 additional subjects for mutations in coding regions of THAP1 and interrogated all published descriptions of THAP1 phenotypes (gender, age of onset, anatomical distribution of dystonia, family history and site of onset) to explore the possibility of THAP1 genotype-phenotype correlations and facilitate a deeper understanding of THAP1 pathobiology. We identified 5 additional missense mutations in THAP1 (p.A7D, p.K16E, p.S21C, p.R29Q, and p.I80V). Three of these variants are associated with appendicular tremors, which were an isolated or presenting sign in some of the affected subjects. Abductor laryngeal dystonia and mild blepharospasm can be manifestations of THAP1 mutations in some individuals. Overall, mean age of onset for THAP1 dystonia is 16.8 years and the most common sites of onset are the arm and neck, and the most frequently affected anatomical site is the neck. In addition, over half of patients exhibit either cranial or laryngeal involvement. Protein truncating mutations and missense mutations within the THAP domain of THAP1 tend to manifest at an earlier age and exhibit more extensive anatomical distributions than mutations localized to other regions of THAP1.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377579      PMCID: PMC3358360          DOI: 10.1016/j.parkreldis.2012.02.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  52 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6).

Authors:  Frank J Kaiser; Alma Osmanoric; Aleksandar Rakovic; Alev Erogullari; Nils Uflacker; Diana Braunholz; Thora Lohnau; Slobodanka Orolicki; Melanie Albrecht; Gabriele Gillessen-Kaesbach; Christine Klein; Katja Lohmann
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

3.  Adult-onset leg dystonia due to a missense mutation in THAP1.

Authors:  Jay A Van Gerpen; Mark S Ledoux; Zbigniew K Wszolek
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

4.  Direct interaction between causative genes of DYT1 and DYT6 primary dystonia.

Authors:  Sophie Gavarini; Corinne Cayrol; Tania Fuchs; Natalia Lyons; Michelle E Ehrlich; Jean-Philippe Girard; Laurie J Ozelius
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

5.  The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias.

Authors:  Raoul Mazars; Anne Gonzalez-de-Peredo; Corinne Cayrol; Anne-Claire Lavigne; Jodi L Vogel; Nathalie Ortega; Chrystelle Lacroix; Violette Gautier; Gaelle Huet; Aurélie Ray; Bernard Monsarrat; Thomas M Kristie; Jean-Philippe Girard
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

Review 6.  Europe the continent with the lowest fertility.

Authors: 
Journal:  Hum Reprod Update       Date:  2010-07-04       Impact factor: 15.610

7.  Mutation screening of the DYT6/THAP1 gene in Italy.

Authors:  Monica Bonetti; Chiara Barzaghi; Francesco Brancati; Alessandro Ferraris; Emanuele Bellacchio; Alessandro Giovanetti; Tamara Ialongo; Giovanna Zorzi; Carla Piano; Martina Petracca; Alberto Albanese; Nardo Nardocci; Bruno Dallapiccola; Anna Rita Bentivoglio; Barbara Garavaglia; Enza Maria Valente
Journal:  Mov Disord       Date:  2009-12-15       Impact factor: 10.338

8.  Novel THAP1 sequence variants in primary dystonia.

Authors:  J Xiao; Y Zhao; R W Bastian; J S Perlmutter; B A Racette; S D Tabbal; M Karimi; R C Paniello; Z K Wszolek; R J Uitti; J A Van Gerpen; D K Simon; D Tarsy; P Hedera; D D Truong; K P Frei; S Dev Batish; A Blitzer; R F Pfeiffer; S Gong; M S LeDoux
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

9.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

10.  Structural determinants of specific DNA-recognition by the THAP zinc finger.

Authors:  Sébastien Campagne; Olivier Saurel; Virginie Gervais; Alain Milon
Journal:  Nucleic Acids Res       Date:  2010-02-09       Impact factor: 16.971

View more
  37 in total

1.  Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.

Authors:  Vikram G Shakkottai; Amit Batla; Kailash Bhatia; William T Dauer; Christian Dresel; Martin Niethammer; David Eidelberg; Robert S Raike; Yoland Smith; H A Jinnah; Ellen J Hess; Sabine Meunier; Mark Hallett; Rachel Fremont; Kamran Khodakhah; Mark S LeDoux; Traian Popa; Cécile Gallea; Stéphane Lehericy; Andreea C Bostan; Peter L Strick
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

2.  Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites.

Authors:  Rachel Saunders-Pullman; Tania Fuchs; Marta San Luciano; Deborah Raymond; Alison Brashear; Robert Ortega; Andres Deik; Laurie J Ozelius; Susan B Bressman
Journal:  Mov Disord       Date:  2014-02-05       Impact factor: 10.338

Review 3.  Recent advances in the genetics of dystonia.

Authors:  Jianfeng Xiao; Satya R Vemula; Mark S LeDoux
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

4.  In-depth Characterization of the Homodimerization Domain of the Transcription Factor THAP1 and Dystonia-Causing Mutations Therein.

Authors:  Alev Richter; Ronja Hollstein; Eva Hebert; Franca Vulinovic; Juliane Eckhold; Alma Osmanovic; Reinhard Depping; Frank J Kaiser; Katja Lohmann
Journal:  J Mol Neurosci       Date:  2017-03-15       Impact factor: 3.444

5.  Reliability of the nanopheres-DNA immunization technology to produce polyclonal antibodies directed against human neogenic proteins.

Authors:  Ahmed Arnaoty; Valérie Gouilleux-Gruart; Sophie Casteret; Bruno Pitard; Yves Bigot; Thierry Lecomte
Journal:  Mol Genet Genomics       Date:  2013-06-07       Impact factor: 3.291

6.  Neural expression of the transcription factor THAP1 during development in rat.

Authors:  Y Zhao; J Xiao; S Gong; J A Clara; M S Ledoux
Journal:  Neuroscience       Date:  2012-12-05       Impact factor: 3.590

7.  Dystonia-Causing Mutations as a Contribution to the Etiology of Spasmodic Dysphonia.

Authors:  Claudio M de Gusmão; Tania Fuchs; Andrew Moses; Trisha Multhaupt-Buell; Phillip C Song; Laurie J Ozelius; Ramon A Franco; Nutan Sharma
Journal:  Otolaryngol Head Neck Surg       Date:  2016-05-17       Impact factor: 3.497

Review 8.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

Review 9.  Emerging common molecular pathways for primary dystonia.

Authors:  Mark S Ledoux; William T Dauer; Thomas T Warner
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 10.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.